Serious adverse effects of selected antiseizure medications used for treatment of focal onset seizures
M Milosavljević, SM Janković - Expert Opinion on Drug Safety, 2025 - Taylor & Francis
Introduction The third-generation antiseizure medications used for the treatment of focal
seizures, lacosamide, eslicarbazepine acetate, perampanel, brivaracetam, and …
seizures, lacosamide, eslicarbazepine acetate, perampanel, brivaracetam, and …
Seizure Reduction with Cenobamate in a Pediatric Patient with Refractory Generalized Epilepsy: A Case Report
M Ranpariya, A Ludwig, EC Rosen, RL Glover - 2024 - researchsquare.com
Cenobamate (CNB) is a newer anti-seizure medication (ASM) approved by Food and Drug
Administration (FDA) for adjunctive treatment of focal onset seizures in adults. Preclinical …
Administration (FDA) for adjunctive treatment of focal onset seizures in adults. Preclinical …